share_log

CVS Health | 8-K: Current report

CVS Health | 8-K: Current report

西維斯健康 | 8-K：重大事件
美股SEC公告 ·  05/23 04:35

Moomoo AI 已提取核心訊息

On May 16, 2024, CVS Health Corporation conducted its 2024 Annual Meeting of Stockholders, where several key proposals were voted upon. The stockholders approved an amendment to the 2017 Incentive Compensation Plan (2017 ICP), which will increase the number of common shares available for issuance by 33.5 million. This amendment had previously received approval from the Management Planning and Development Committee and the Board of Directors, contingent on stockholder approval. The meeting also resulted in the election of 12 nominees to the Board of Directors for a one-year term, the ratification of Ernst & Young LLP as the independent registered public accounting firm for 2024, and the advisory approval of the compensation of the company's named executive officers. However, four stockholder proposals were not approved. The detailed voting results for each proposal were provided in the report. The amended 2017 ICP and the forms of award agreements to be used under the plan were filed as exhibits to the report.
On May 16, 2024, CVS Health Corporation conducted its 2024 Annual Meeting of Stockholders, where several key proposals were voted upon. The stockholders approved an amendment to the 2017 Incentive Compensation Plan (2017 ICP), which will increase the number of common shares available for issuance by 33.5 million. This amendment had previously received approval from the Management Planning and Development Committee and the Board of Directors, contingent on stockholder approval. The meeting also resulted in the election of 12 nominees to the Board of Directors for a one-year term, the ratification of Ernst & Young LLP as the independent registered public accounting firm for 2024, and the advisory approval of the compensation of the company's named executive officers. However, four stockholder proposals were not approved. The detailed voting results for each proposal were provided in the report. The amended 2017 ICP and the forms of award agreements to be used under the plan were filed as exhibits to the report.
2024年5月16日，CVS Health Corporation舉行了2024年年度股東大會，會上對幾項關鍵提案進行了表決。股東批准了2017年激勵薪酬計劃（2017年ICP）的修正案，該修正案將使可供發行的普通股數量增加3,350萬股。該修正案此前已獲得管理規劃與發展委員會和董事會的批准，但須經股東批准。會議還選舉了12名董事會候選人，任期一年，安永會計師事務所批准爲2024年的獨立註冊會計師事務所，並諮詢性地批准了公司指定執行官的薪酬。但是，有四份股東提案未獲批准。報告中提供了每項提案的詳細投票結果。經修訂的2017年ICP和計劃中使用的獎勵協議形式已作爲報告的證物提交。
2024年5月16日，CVS Health Corporation舉行了2024年年度股東大會，會上對幾項關鍵提案進行了表決。股東批准了2017年激勵薪酬計劃（2017年ICP）的修正案，該修正案將使可供發行的普通股數量增加3,350萬股。該修正案此前已獲得管理規劃與發展委員會和董事會的批准，但須經股東批准。會議還選舉了12名董事會候選人，任期一年，安永會計師事務所批准爲2024年的獨立註冊會計師事務所，並諮詢性地批准了公司指定執行官的薪酬。但是，有四份股東提案未獲批准。報告中提供了每項提案的詳細投票結果。經修訂的2017年ICP和計劃中使用的獎勵協議形式已作爲報告的證物提交。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

獨立文件3  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間